Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Mata

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Thrombosis and Haemostasis|July 17, 2015
High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosisRosa Suades, Teresa Padró, Rodrigo Alonso, et al.
Journal of Lipid Research|April 27, 2016
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemiaJudit Cubedo, Teresa Padró, Rodrigo Alonso, et al.
Thrombosis and Haemostasis|June 7, 2013
Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cellsRosa Suades, Teresa Padró, Rodrigo Alonso, et al.
The Lancet. Diabetes & Endocrinology|July 28, 2016
Lipoprotein(a) and familial hypercholesterolaemiaLeopoldo Pérez de Isla, Adriana Saltijeral Cerezo, Rodrigo Alonso, et al.
Vascular Health and Risk Management|February 6, 2020
Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient CareRodrigo Alonso, Leopoldo Perez de Isla, Ovidio Muñiz-Grijalvo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 20, 2018
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemiaRafael Escate, Pedro Mata, Jose Maria Cepeda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2020
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemiaRafael Escate, Pedro Mata, Jose Maria Cepeda, et al.
Medicina Clinica|December 29, 2014
[Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B]Rodrigo Alonso, Pedro Mata, Moises Alonso Y Gregorio, et al.
Expert Review of Cardiovascular Therapy|March 9, 2013
Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomesRodrigo Alonso, Pedro Mata, Daniel Zambón, et al.
Frontiers in Genetics|May 16, 2022
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of CareWann Jia Loh, Dick C Chan, Pedro Mata, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Thrombosis and Haemostasis|July 17, 2015
High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosisRosa Suades, Teresa Padró, Rodrigo Alonso, et al.
Journal of Lipid Research|April 27, 2016
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemiaJudit Cubedo, Teresa Padró, Rodrigo Alonso, et al.
Thrombosis and Haemostasis|June 7, 2013
Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cellsRosa Suades, Teresa Padró, Rodrigo Alonso, et al.
The Lancet. Diabetes & Endocrinology|July 28, 2016
Lipoprotein(a) and familial hypercholesterolaemiaLeopoldo Pérez de Isla, Adriana Saltijeral Cerezo, Rodrigo Alonso, et al.
Vascular Health and Risk Management|February 6, 2020
Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient CareRodrigo Alonso, Leopoldo Perez de Isla, Ovidio Muñiz-Grijalvo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 20, 2018
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemiaRafael Escate, Pedro Mata, Jose Maria Cepeda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2020
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemiaRafael Escate, Pedro Mata, Jose Maria Cepeda, et al.
Medicina Clinica|December 29, 2014
[Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B]Rodrigo Alonso, Pedro Mata, Moises Alonso Y Gregorio, et al.
Expert Review of Cardiovascular Therapy|March 9, 2013
Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomesRodrigo Alonso, Pedro Mata, Daniel Zambón, et al.
Frontiers in Genetics|May 16, 2022
Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of CareWann Jia Loh, Dick C Chan, Pedro Mata, et al.
Pageof 15